Conversion from migraine without aura to typical aura without headache after irbesartan by unknown
2002, the patient developed mild
arterial hypertension and her family
physician prescribed irbesartan 150
mg daily. In the following months,
the patient perceived a significant
reduction of headache attacks.
However, in January 2003 the patient
developed an attack of migraine aura
without headache. She reported
symptoms of a scintillating scotoma,
gradually expanding across the right
visual field and lasting for approxi-
mately 30 min. The aura was not fol-
lowed by headache. The patient had
seven additional attacks in a two-year
period, with the same clinical fea-
tures. All the attacks fulfilled the
ICHD-II criteria for ‘Typical aura
without headache’ (code 1.2.3).
Magnetic resonance imaging scan of
the brain did not reveal any abnor-
malities. Extensive blood testing was
normal. Factor V Leiden (R506Q)
and prothrombin (G20210A) gene
mutations were absent.
This is the first case, to our
knowledge, describing the conver-
sion of MO into typical aura without
headache after antihypertensive the-
rapy. Mammalian brain harbours a
renin-angiotensin system [3] and
angiotensin receptors (AT1, AT2 and
AT4) are plentiful in human brain.
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Sir,
There is a long and still open
controversy over whether migraine
with aura (MA) and migraine with-
out aura (MO) are separate entities
or subtypes of the same disorder [1].
We report the case of a patient suf-
fering from MO that, after starting
an antihypertensive therapy with
irbesartan, experienced a significant
reduction of MO attacks but devel-
oped typical aura without headache.
A 51-year-old Caucasian woman
was admitted in February 2003 as an
out-patient in our Headache Center
for episodes of scintillating scotoma
affecting right visual field. Since age
27, the patient had complained of
headache attacks fulfilling the ICHD-
II criteria [2] for MO. In December
role for angiotensin receptors in the
pathophysiology of migraine aura.
Additional clinical and experimen-
tal studies may be helpful to clarify
this issue.
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